These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32572912)

  • 1. MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2.
    Li P; Wu Q; Yang XR; Sun T
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5988-5995. PubMed ID: 32572912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
    Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
    Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
    He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
    Deng JH; Zheng GY; Li HZ; Ji ZG
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1].
    Lei K; Xie W; Sun T; Liu Y; Wang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):712-717. PubMed ID: 35673915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-155-5p Targets NR3C2 to Promote Malignant Progression of Clear Cell Renal Cell Carcinoma.
    Yan C; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Meng B
    Kidney Blood Press Res; 2022; 47(5):354-362. PubMed ID: 35078194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
    Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
    Urol Int; 2021; 105(9-10):906-915. PubMed ID: 34192708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-204-5p Hampers the Malignant Progression of Clear Cell Renal Cell Carcinoma through GXYLT2 Downregulation.
    Wu Y; Liao Q
    Kidney Blood Press Res; 2022; 47(11):654-663. PubMed ID: 36063796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
    Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
    Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Let-7i-5p enhances cell proliferation, migration and invasion of ccRCC by targeting HABP4.
    Liu Y; Hu X; Hu L; Xu C; Liang X
    BMC Urol; 2021 Mar; 21(1):49. PubMed ID: 33775245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs MiR-15a and MiR-26a cooperatively regulate O-GlcNAc-transferase to control proliferation in clear cell renal cell carcinoma.
    Kalantzakos TJ; Sullivan TB; Sebel LE; Canes D; Burks EJ; Moinzadeh A; Rieger-Christ KM
    Cancer Biomark; 2021; 30(3):343-351. PubMed ID: 33337348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-195-5p inhibits malignant progression of gallbladder cancer by regulating Wnt3a.
    Sun HD
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7635-7642. PubMed ID: 34982425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma.
    Wang XG; Zhu YW; Wang T; Chen B; Xing JC; Xiao W
    Kaohsiung J Med Sci; 2021 Mar; 37(3):192-199. PubMed ID: 33151036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
    Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
    Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.
    Lu J; Wei JH; Feng ZH; Chen ZH; Wang YQ; Huang Y; Fang Y; Liang YP; Cen JJ; Pan YH; Liao B; Chen WF; Chen W; Luo JH
    Oncotarget; 2017 Mar; 8(13):21461-21471. PubMed ID: 28423523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.
    Kowalik CG; Palmer DA; Sullivan TB; Teebagy PA; Dugan JM; Libertino JA; Burks EJ; Canes D; Rieger-Christ KM
    BJU Int; 2017 Sep; 120(3):428-440. PubMed ID: 28432832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.